Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
9/24/26 16:26 | 9/23/26 | BNTX | Health | BioPrd | Biological Products, (No Diag | Sahin Ugur | OT | CEO | S.m | -6,843 | 99.17 | 0 | -69 | 0 | 39,559 | D | |||||||||||||||
9/22/26 17:04 | 9/21/26 | BNTX | Health | BioPrd | Biological Products, (No Diag | Sahin Ugur | OT | CEO | S.m | -7,861 | 99.50 | 0 | -79 | 0 | 39,628 | D | |||||||||||||||
9/18/26 16:41 | 9/17/26 | BNTX | Health | BioPrd | Biological Products, (No Diag | Sahin Ugur | OT | CEO | S.m | -6,239 | 97.49 | 0 | -64 | 0 | 39,707 | D | |||||||||||||||
9/16/26 16:46 | 9/15/26 | BNTX | Health | BioPrd | Biological Products, (No Diag | Sahin Ugur | OT | CEO | S.m | -4,722 | 96.37 | 0 | -49 | 0 | 39,771 | D | |||||||||||||||
9/11/26 17:18 | 9/10/26 | BNTX | Health | BioPrd | Biological Products, (No Diag | Sahin Ugur | OT | CEO | S | -1,974 | 96.31 | 0 | -21 | 0 | 39,906 | D | |||||||||||||||
9/9/26 17:29 | 9/8/26 | BNTX | Health | BioPrd | Biological Products, (No Diag | Sahin Ugur | OT | CEO | S.m | -7,191 | 98.50 | 0 | -73 | 0 | 39,927 | D | |||||||||||||||
9/8/26 16:10 | 9/3/26 | BNTX | Health | BioPrd | Biological Products, (No Diag | Sahin Ugur | OT | CEO | S.m | -7,889 | 103.13 | 0 | -77 | -9 | 782 | D | |||||||||||||||
4/23/26 16:02 | 4/22/26 | BNTX | Health | BioPrd | Biological Products, (No Diag | Poetting Sierk | O | COO | S | -5,528 | 110.56 | 0 | -50 | -11 | 399 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |